Authors:
Schroder, H
Agger, KE
Rosthoj, S
Carlsen, AT
Schmiegelow, K
Citation: H. Schroder et al., Antibacterial prophylaxis with trimethoprim-sulfamethoxazole during induction treatment for acute lymphoblastic leukemia, DAN MED B, 48(4), 2001, pp. 275-277
Authors:
Schmiegelow, K
Nyvold, C
Seyfarth, J
Pieters, R
Rottier, MMA
Knabe, N
Ryder, LP
Madsen, HO
Svejgaard, A
Kaspers, GJL
Citation: K. Schmiegelow et al., Post-induction residual leukemia in childhood acute lymphoblastic leukemiaquantified by PCR correlates with in vitro prednisolone resistance, LEUKEMIA, 15(7), 2001, pp. 1066-1071
Authors:
Andersen, MT
Nordentoft, I
Hjalgrim, LL
Christiansen, CL
Jakobsen, VD
Hjalgrim, H
Pallisgaard, N
Madsen, HO
Christiansen, M
Ryder, LP
Clausen, N
Hokland, P
Schmiegelow, K
Melbye, M
Jorgensen, P
Citation: Mt. Andersen et al., Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia, LEUKEMIA, 15(5), 2001, pp. 858-859
Citation: K. Schmiegelow et U. Bretton-meyer, 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia, LEUKEMIA, 15(1), 2001, pp. 74-79
Authors:
Albertsen, BK
Jakobsen, P
Schroder, H
Schmiegelow, K
Carlsen, NT
Citation: Bk. Albertsen et al., Pharmacokinetics of Erwinia asparaginase after intravenous and intramuscular administration, CANC CHEMOT, 48(1), 2001, pp. 77-82
Authors:
Albertsen, BK
Schroder, H
Jakobsen, P
Muller, HJ
Carlsen, NT
Schmiegelow, K
Citation: Bk. Albertsen et al., Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries, BR J CL PH, 52(4), 2001, pp. 433-437
Authors:
Poulsen, A
Demeny, AK
Plum, CB
Nielsen, KG
Schmiegelow, K
Citation: A. Poulsen et al., Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia, MED PED ONC, 37(1), 2001, pp. 20-23
Authors:
Eldrup, E
Clausen, N
Scherling, B
Schmiegelow, K
Citation: E. Eldrup et al., Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma, SC J CL INV, 61(6), 2001, pp. 479-490
Authors:
Schmiegelow, M
Lassen, S
Poulsen, HS
Schmiegelow, K
Hertz, H
Andersson, AM
Skakkebaek, NE
Muller, J
Citation: M. Schmiegelow et al., Gonadal status in male survivors following childhood brain tumors (vol 86,pg 2446, 2001), J CLIN END, 86(8), 2001, pp. 3967-3967
Authors:
Gustafsson, G
Schmiegelow, K
Forestier, E
Clausen, N
Glomstein, A
Jonmundsson, G
Mellander, L
Makipernaa, A
Nygaard, R
Saarinen-Pihkala, UM
Citation: G. Gustafsson et al., Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation, LEUKEMIA, 14(12), 2000, pp. 2267-2275
Authors:
Schmiegelow, M
Lassen, S
Poulsen, HS
Feldt-Rasmussen, U
Schmiegelow, K
Hertz, H
Muller, J
Citation: M. Schmiegelow et al., Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhoodbrain tumors, HORMONE RES, 54(2), 2000, pp. 53-59
Authors:
Schmiegelow, M
Lassen, S
Poulsen, HS
Feldt-Rasmussen, U
Schmiegelow, K
Hertz, H
Muller, J
Citation: M. Schmiegelow et al., Cranial radiotherapy of childhood brain tumours: Growth hormone deficiencyand its relation to the biological effective dose of irradiation in a large population based study, CLIN ENDOCR, 53(2), 2000, pp. 191-197
Authors:
Nyvold, C
Madsen, HO
Ryder, LP
Seyfarth, J
Engel, CA
Svejgaard, A
Wesenberg, F
Schmiegelow, K
Citation: C. Nyvold et al., Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia, J IMMUNOL M, 233(1-2), 2000, pp. 107-118
Authors:
Ramakers-van Woerden, NL
Pieters, R
Loonen, AH
Hubeek, I
van Drunen, E
Beverloo, HB
Slater, RM
Harbott, J
Seyfarth, J
van Wering, ER
Hahlen, K
Schmiegelow, K
Janka-Schaub, GE
Veerman, AJP
Citation: Nl. Ramakers-van Woerden et al., TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia, BLOOD, 96(3), 2000, pp. 1094-1099
Authors:
Schmiegelow, M
Hertz, H
Schmiegelow, K
Holm, K
Muller, J
Citation: M. Schmiegelow et al., Insulin-like growth factor-I and insulin-like growth factor binding protein-3 during maintenance chemotherapy of acute lymphoblastic leukemia in children (vol 21, pg 268, 1999), J PED H ONC, 21(6), 1999, pp. 562-562
Authors:
Schmiegelow, M
Hertz, H
Schmiegelow, K
Holm, K
Muller, J
Citation: M. Schmiegelow et al., Insulin-like growth factor-I and insulin-like growth factor binding protein-3 during maintenance chemotherapy of acute lymphoblastic leukemia in children, J PED H ONC, 21(4), 1999, pp. 268-273
Authors:
Thomsen, JB
Schroder, H
Kristinsson, J
Madsen, B
Szumlanski, C
Weinshilboum, R
Andersen, JB
Schmiegelow, K
Citation: Jb. Thomsen et al., Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells- Relation to thiopurine metabolism, CANCER, 86(6), 1999, pp. 1080-1086